Loading clinical trials...
Loading clinical trials...
The goal of this randomized clinical trial is to evaluate the clinical and radiographic success of pulpotomy using Neoputty MTA vital primary molars diagnosed with symptomatic irreversible pulpitis. ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Cairo University
NCT07297836 · Pulpitis - Irreversible, Pulp Necrosis, and more
NCT07340606 · Pulpitis - Irreversible
NCT07306533 · Pulpitis - Irreversible
NCT06854744 · Pulpitis - Irreversible, Ozone, and more
NCT06573710 · Pulpitis - Irreversible
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions